Cancer Detection and Treatment: The Role of Nanomedicines
暂无分享,去创建一个
[1] F. Esteva,et al. Her2-positive breast cancer: herceptin and beyond. , 2008, European journal of cancer.
[2] Shaker A Mousa,et al. Emerging nanopharmaceuticals. , 2008, Nanomedicine : nanotechnology, biology, and medicine.
[3] Ralph Weissleder,et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. , 2003, The New England journal of medicine.
[4] J. B. Loefer. Growth of sarcoma in hypophysectomized rats , 1952, Cancer.
[5] Michele Follen,et al. Real-time vital optical imaging of precancer using anti-epidermal growth factor receptor antibodies conjugated to gold nanoparticles. , 2003, Cancer research.
[6] M. Delano,et al. Emerging implications of nanotechnology on cancer diagnostics and therapeutics , 2006, Cancer.
[7] Michael Hawkins,et al. Comparative Preclinical and Clinical Pharmacokinetics of a Cremophor-Free, Nanoparticle Albumin-Bound Paclitaxel (ABI-007) and Paclitaxel Formulated in Cremophor (Taxol) , 2005, Clinical Cancer Research.
[8] H. Rothuizen,et al. Translating biomolecular recognition into nanomechanics. , 2000, Science.
[9] D. Patel,et al. Clinical Use of Anti‐Epidermal Growth Factor Receptor Monoclonal Antibodies in Metastatic Colorectal Cancer , 2008, Pharmacotherapy.
[10] Shiladitya Sengupta,et al. Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system , 2005, Nature.
[11] Vladimir P Torchilin,et al. Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo , 2005, Nature Medicine.
[12] Iftach Yacoby,et al. Targeted Drug-Carrying Bacteriophages as Antibacterial Nanomedicines , 2007, Antimicrobial Agents and Chemotherapy.
[13] G. Kwon,et al. Polymeric micelles for delivery of poorly water-soluble compounds. , 2003, Critical reviews in therapeutic drug carrier systems.
[14] H. Maeda,et al. Exploiting the enhanced permeability and retention effect for tumor targeting. , 2006, Drug discovery today.
[15] Xiaohua Huang,et al. Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles. , 2006, Cancer letters.
[16] R. Lerner,et al. A cell-penetrating peptide from a novel pVII-pIX phage-displayed random peptide library. , 2002, Bioorganic & medicinal chemistry.
[17] Igor L. Medintz,et al. Quantum dot bioconjugates for imaging, labelling and sensing , 2005, Nature materials.
[18] S. Gettinger. Targeted therapy in advanced non-small-cell lung cancer. , 2008, Seminars in respiratory and critical care medicine.
[19] Kazunori Kataoka,et al. Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. , 2006, Pharmacology & therapeutics.
[20] J. Richie,et al. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[21] M. Bruchez,et al. Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots , 2003, Nature Biotechnology.
[22] T. Xu,et al. Pharmaceutical applications of dendrimers: promising nanocarriers for drug delivery. , 2008, Frontiers in bioscience : a journal and virtual library.
[23] Edith A Perez,et al. Nanoparticle albumin-bound paclitaxel (ABI-007): a newer taxane alternative in breast cancer. , 2005, Future oncology.
[24] S. Bhatia,et al. Probing the Cytotoxicity Of Semiconductor Quantum Dots. , 2004, Nano letters.
[25] J. Manola,et al. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. , 1999, The New England journal of medicine.
[26] Rakesh K Jain,et al. Antiangiogenic therapy for cancer: current and emerging concepts. , 2005, Oncology.
[27] M. Ferrari. Cancer nanotechnology: opportunities and challenges , 2005, Nature Reviews Cancer.
[28] Erkki Ruoslahti,et al. Nanocrystal targeting in vivo , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[29] Leon Hirsch,et al. Nanoshell-Enabled Photonics-Based Imaging and Therapy of Cancer , 2004, Technology in cancer research & treatment.
[30] T. Xu,et al. Design, synthesis and potent pharmaceutical applications of glycodendrimers: a mini review. , 2007, Current drug discovery technologies.
[31] F. Marshall,et al. In vivo molecular and cellular imaging with quantum dots. , 2005, Current opinion in biotechnology.
[32] T. Thundat,et al. Bioassay of prostate-specific antigen (PSA) using microcantilevers , 2001, Nature Biotechnology.
[33] J. Post,et al. Quantum dot ligands provide new insights into erbB/HER receptor–mediated signal transduction , 2004, Nature Biotechnology.
[34] A. C. Hunter,et al. Nanomedicine: current status and future prospects , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[35] J. West,et al. Immunotargeted nanoshells for integrated cancer imaging and therapy. , 2005, Nano letters.
[36] H. Maeda,et al. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.
[37] A. Majumdar,et al. Cantilever arrays for multiplexed mechanical analysis of biomolecular reactions. , 2004, Mechanics & chemistry of biosystems : MCB.
[38] R. Sasisekharan,et al. Exploiting nanotechnology to target cancer , 2007, British Journal of Cancer.
[39] I. Yacoby,et al. Killing cancer cells by targeted drug-carrying phage nanomedicines , 2008, BMC biotechnology.
[40] Y. Liu,et al. Mechanistic studies of a peptidic GRP78 ligand for cancer cell-specific drug delivery. , 2007, Molecular pharmaceutics.
[41] R. Skalak,et al. Time-dependent behavior of interstitial fluid pressure in solid tumors: implications for drug delivery. , 1995, Cancer research.
[42] H. Maeda,et al. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[43] Shuming Nie,et al. Multicolor quantum dots for molecular diagnostics of cancer , 2006, Expert review of molecular diagnostics.
[44] R. Stafford,et al. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[45] Bradford G Orr,et al. Direct observation of lipid bilayer disruption by poly(amidoamine) dendrimers. , 2004, Chemistry and physics of lipids.
[46] R Weissleder,et al. Monocrystalline iron oxide nanocompounds (MION): Physicochemical properties , 1993, Magnetic resonance in medicine.
[47] Jun Fang,et al. Vascular permeability enhancement in solid tumor: various factors, mechanisms involved and its implications. , 2003, International immunopharmacology.
[48] K. Kono,et al. Synthesis of polyamidoamine dendrimers having poly(ethylene glycol) grafts and their ability to encapsulate anticancer drugs. , 2000, Bioconjugate chemistry.
[49] Michael Hawkins,et al. Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[50] W. D. de Jong,et al. Drug delivery and nanoparticles: Applications and hazards , 2008, International journal of nanomedicine.
[51] Rakesh K. Jain,et al. Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy , 2001, Nature Medicine.
[52] John W. Park. Liposome-based drug delivery in breast cancer treatment , 2002, Breast Cancer Research.
[53] Shuming Nie,et al. Emerging use of nanoparticles in diagnosis and treatment of breast cancer. , 2006, The Lancet. Oncology.